MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,275,079 | -24.1% | 179,917 | +20.0% | 3.87% | -31.9% |
Q2 2023 | $34,630,827 | -4.6% | 149,917 | 0.0% | 5.68% | -19.8% |
Q1 2023 | $36,318,892 | -56.6% | 149,917 | -48.0% | 7.08% | -52.0% |
Q4 2022 | $83,607,674 | +4187.6% | 288,054 | +860.2% | 14.76% | +2422.4% |
Q3 2022 | $1,950,000 | – | 30,000 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |